The Russian gonococcal antimicrobial susceptibility programme (RU-GASP) - national resistance prevalence in 2007 and 2008, and trends during 2005-2008

Eurosurveillance

Volumn 15, Issue 14, 2010, Pages

  Kubanova, A ^a   Frigo, N ^a   Kubanov, A ^a   Sidorenko, S ^a   Lesnaya, I ^a   Polevshikova, S ^a   Solomka, V ^a   Bukanov, N ^a   Domeika, M ^b   Unemo, M ^c  

^a Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology   (Russian Federation)

^b UPPSALA UNIVERSITY   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951043519     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. World Health Organization. Gonorrhoea - Incidence rate (per 100,000 population). WHO Regional Office for Europe. Centralized information system for infectious diseases (CISID)/ Sexually transmitted infections (STI). Available from: http://data.euro.who.int/cisid
2. Statistical information from the State Epidemiologic Surveillance Centre for Communicable Diseases by the Health Ministry of the Russian Federation. [Morbidity due to infections in the Russian Federation during 2007-2008]. Moscow, Russia. [Russian].
3. Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821-34.
4. Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother. 2009;63:1142-51.
5. Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell. 2009;33(3):268-74.
6. Bala M, Jain RK, Ray K. Antimicrobial susceptibility profile of resistance phenotypes of Neisseria gonorrhoeae in India. Sex Transm Dis. 2008;35(6):588-91.
7. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Disease Surveillance, 2007. Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report 2007. Atlanta, GA; 2009. Available from: http://www.cdc.gov/std/stats07/gonorrhea.htm#a14
8. Deguchi T, Yasuda M. Lack of nationwide surveillance of antimicrobial resistance in Neisseria gonorrhoeae in Japan. Ann Intern Med. 2008;149(5):363-4.
9. GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2007 report. London: Health Protection Agency 2008. Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1221117895841
10. Kubanova A, Frigo N, Kubanov A, et al. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia. Sex Transm Inf. 2008;84(4):285-9.
11. Martin IM, Hoffman S, Ison CA; ESSTI Network. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother. 2006;58:587-93.
12. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2006. Commun Dis Intell. 2008;32(1):48-51.
13. WHO GASP Document. Rationale and applications for the current (2008) WHO panel of Neisseria gonorrhoeae for antimicrobial resistance surveillance for public health purposes, and instructions for their use. In: Technical document D007-0408-1#1 (2008) Sydney: WHO Collaborating Centre for STD.
14. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148(8):606-13.
15. EG, Gerasimova NM, Sergeev AG, Skidan NI, Shcherbakova NV, Churakov AS. [Sensitivity of clinical strains of Neisseria gonorrhoeae circulating in Yekaterinburg and the Sverdlovsk region]. Klin Lab Diagn. 2005:(4):41-2. [Russian].
16. VA, Il'una EN, Malakhova MV, Zubkov MM, Sidorenlo SV, Kubanova AA, et al. [Resistance of Russian isolates of Neisseria gonorrhoeae to fluoroquinolones]. Mol Gen Mikrobiol Virusol. 2005;(1):23-7. [Russian].
17. Vorobieva V, Firsova N, Ababkova T, et al. Antibiotic susceptibility of Neisseria gonorrhoeae in Arkhangelsk, Russia. Sex Transm Infect. 2007;83:133-5.
18. Zoubkov M, Kubanova A, Vahnina T, Leniv I, Haldorsen BC, Unemo M, et al. Antimicrobial resistance of Neisseria gonorrhoeae, and emerging fluoroquinolone resistance in Russia. Clin Microbiol Infect. 2007;83(2):133-5
19. Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute 27: 1-182, 2007.
20. Boslego JW, Tramont EC, Takafuji ET, Diniega BM, Mitchell BS, Small JW, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1987;317(5):272-8.
21. Palmer HM, Young H, Winter A, Dave J. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J Antimicrob Chemother. 2008;62(3):490-4.
22. Chisholm SA, Neal TJ, Alawattegama AB, Birley HD, Howe RA, Ison CA. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother. 2009;64(2):353-8.
23. Starnino S, Stefanelli P; Neisseria gonorrhoeae Italian Study Group. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemother. 2009;63(6):1200-4.
24. Unemo M, Savicheva A, Budilovskaya O, Sokolovsky E, Larsson M, Domeika M. Laboratory diagnosis of Neisseria gonorrhoeae in St Petersburg, Russia: inventory, performance characteristics and recommended optimisations. Sex Transm Infect. 2006;82(1):41-4.
25. Unemo M, Vorobieva V, Firsova N, Ababkova T, Leniv I, Haldorsen BC, et al. Neisseria gonorrhoeae population in Arkhangelsk, Russia: phenotypic and genotypic heterogeneity. Clin Microbiol Infect. 2007;13(9):873-8.
26. CJ; European branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization. European guideline for the management of gonorrhoea. Int J STD AIDS. 2001;12 Suppl 3:27-9.
27. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:1-100.
28. Savicheva A, Sokolovsky E, Frigo N, et al. Guidelines for laboratory diagnosis of Neisseria gonorrhoeae in East-European countries. Part 1: Gonorrhoea, sampling, and microscopy for diagnosis. Acta Medica Lituanica. 2007;14:65-74.
29. Savicheva A, Sokolovsky E, Frigo N, Priputnevich T, Brilene T, Deák J, et al. Guidelines for laboratory diagnosis of Neisseria gonorrhoeae in East-European countries. Part 2. Culture, non-culture methods, determination of antibiotic resistance, and quality assurance. Acta Medica Lituanica. 2007;14:123-34.
30. E, Guschin A, Maximova A, Tseslyuk M, Savicheva A, Sokolovsky E, et al. Comparison of microscopy, culture and in-house PCR and NASBA assays for diagnosis of Neisseria gonorrhoeae in Russia. APMIS. 2008;116(2):133-8. 31.
31. Van Dyck E, Meheus AZ, Piot P. Gonorrhoea. In: Laboratory diagnosis of sexually transmitted diseases. World Health Organization (WHO), Geneva; 1999:1-21.
32. World Health Organization. Management of sexually transmitted diseases, WHO/GPA/TEM94. 1 Rev 1. Geneva: WHO, 1997. Available from: http://whqlibdoc.who.int/hq/1994/WHOGPATEM94.1Rev.1.pdf
33. Shipitsyna E, Zolotoverkhaya E, Hjelmevoll SO, Maximova A, Savicheva A, Sokolovsky E, et al. Evaluation of six nucleic acid amplification tests used for diagnosis of Neisseria gonorrhoeae in Russia compared with an international strictly validated real-time porA pseudogene polymerase chain reaction. J Eur Acad Dermatol Venereol. 2009;23(11):1246-53.
34. Unemo M, Olcén P, Fredlund H, Thulin S. Real-time PCR and subsequent pyrosequencing for screening of penA mosaic alleles and prediction of reduced susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae. APMIS. 2008;116(11):1004-8.
35. Whiley D, Bates J, Limnios A, Nissen MD, Tapsall J, Sloots TP. Use of a novel screening PCR indicates presence of Neisseria gonorrhoeae isolates with a mosaic penA gene sequence in Australia. Pathology. 2007;39(4):445-6.